Gurvinder Kaur Mahajan’s Post

Generative AI, AI/ML, Cloud Strategist driving Business Innovation, CxO Executive Strategic Advisor, BioPharma and BioTech

2mo

Speed-up drug discovery and lower costs…

Matt Garman

2mo Edited

What’s happening with generative AI in healthcare & life sciences is pretty exciting. Today, EvolutionaryScale launched their cutting-edge ESM3 model for researchers and scientists, and it’s available on Amazon Web Services (AWS). ESM3 has the remarkable ability to generate entirely new proteins that have never existed before, allowing for “programmable biology.” Models like ESM3 have the potential to significantly speed drug discovery timelines and lower costs. The open-source ESM3 is available today through Amazon SageMaker and AWS HealthOmics, with the full model family coming to these services and Amazon Bedrock soon. We look forward to making it easier for scientists everywhere to use GenAI for drug discovery and development. https://lnkd.in/gVrA_zhu

To view or add a comment, sign in

More Relevant Posts

Zev Yanovich

Sales Leader - Generative Artificial Intelligence
2mo
Report this post
The next GenAI frontier is in the Healthcare and Life Sciences area. Incredible to see how the AWS approach of providing customers model choice continues to be the keystone for how customers can leverage the best models to addresses their many use cases.
Matt Garman Matt Garman is an Influencer
2mo Edited

What’s happening with generative AI in healthcare & life sciences is pretty exciting. Today, EvolutionaryScale launched their cutting-edge ESM3 model for researchers and scientists, and it’s available on Amazon Web Services (AWS). ESM3 has the remarkable ability to generate entirely new proteins that have never existed before, allowing for “programmable biology.” Models like ESM3 have the potential to significantly speed drug discovery timelines and lower costs. The open-source ESM3 is available today through Amazon SageMaker and AWS HealthOmics, with the full model family coming to these services and Amazon Bedrock soon. We look forward to making it easier for scientists everywhere to use GenAI for drug discovery and development. https://lnkd.in/gVrA_zhu
Like Comment
To view or add a comment, sign in
Ignacio de Leon ☁

Sales and Partners Strategy and Operations Lead @ Amazon Web Services (AWS) | MBA
2mo
Report this post
If you want to learn more about how AWS looks forward to making it easier for scientists everywhere to use GenAl for drug discovery and development, try this. https://Inkd.in/gVrA_zhu
Matt Garman Matt Garman is an Influencer
2mo Edited

What’s happening with generative AI in healthcare & life sciences is pretty exciting. Today, EvolutionaryScale launched their cutting-edge ESM3 model for researchers and scientists, and it’s available on Amazon Web Services (AWS). ESM3 has the remarkable ability to generate entirely new proteins that have never existed before, allowing for “programmable biology.” Models like ESM3 have the potential to significantly speed drug discovery timelines and lower costs. The open-source ESM3 is available today through Amazon SageMaker and AWS HealthOmics, with the full model family coming to these services and Amazon Bedrock soon. We look forward to making it easier for scientists everywhere to use GenAI for drug discovery and development. https://lnkd.in/gVrA_zhu
Like Comment
To view or add a comment, sign in
John Holland
2mo
Report this post
ESM3 is now available on AWS! This is such an exciting announcement from EvolutionaryScale! EvolutionaryScale’s ESM3 is a groundbreaking frontier generative model for biology that reasons jointly over sequence, structure, and function, a capability unmatched by previous protein language models. Trained on multiple modalities and billions of protein sequences spanning 3.8 billion years of evolution, ESM3 can understand complex biological data from various sources and generate entirely new proteins that have never existed in nature. The ESM3 model family includes three proprietary models (98B parameter, 7B parameter and 1.4B parameter versions) and one open-source model (1.4B parameter), with the open-source version available to AWS customers today on Amazon SageMaker and AWS HealthOmics and coming later this year to Amazon Bedrock.
Matt Garman Matt Garman is an Influencer
2mo Edited

What’s happening with generative AI in healthcare & life sciences is pretty exciting. Today, EvolutionaryScale launched their cutting-edge ESM3 model for researchers and scientists, and it’s available on Amazon Web Services (AWS). ESM3 has the remarkable ability to generate entirely new proteins that have never existed before, allowing for “programmable biology.” Models like ESM3 have the potential to significantly speed drug discovery timelines and lower costs. The open-source ESM3 is available today through Amazon SageMaker and AWS HealthOmics, with the full model family coming to these services and Amazon Bedrock soon. We look forward to making it easier for scientists everywhere to use GenAI for drug discovery and development. https://lnkd.in/gVrA_zhu
1 Comment
Like Comment
To view or add a comment, sign in
Matt Garman Matt Garman is an Influencer
2mo Edited
Report this post
What’s happening with generative AI in healthcare & life sciences is pretty exciting. Today, EvolutionaryScale launched their cutting-edge ESM3 model for researchers and scientists, and it’s available on Amazon Web Services (AWS). ESM3 has the remarkable ability to generate entirely new proteins that have never existed before, allowing for “programmable biology.” Models like ESM3 have the potential to significantly speed drug discovery timelines and lower costs. The open-source ESM3 is available today through Amazon SageMaker and AWS HealthOmics, with the full model family coming to these services and Amazon Bedrock soon. We look forward to making it easier for scientists everywhere to use GenAI for drug discovery and development. https://lnkd.in/gVrA_zhu
74 Comments
Like Comment
To view or add a comment, sign in
Carina Kemp

Research computing & research data expert. Accelerating research in the cloud. Passionate about high performing culture, leading diverse teams to enable & the application of Future Technologies for innovation.
2mo
Report this post
This is really exciting. This is why AWS has recently joined the Trillion Parameter Consortium. Because we want to work with scientists across the world to accelerate their research and do our bit to solve our and future generations global challenges. We are only just starting to see the potential of Generative AI for research. #ResearchInTheCloud Amazon Web Services (AWS)
Matt Garman Matt Garman is an Influencer
2mo Edited

What’s happening with generative AI in healthcare & life sciences is pretty exciting. Today, EvolutionaryScale launched their cutting-edge ESM3 model for researchers and scientists, and it’s available on Amazon Web Services (AWS). ESM3 has the remarkable ability to generate entirely new proteins that have never existed before, allowing for “programmable biology.” Models like ESM3 have the potential to significantly speed drug discovery timelines and lower costs. The open-source ESM3 is available today through Amazon SageMaker and AWS HealthOmics, with the full model family coming to these services and Amazon Bedrock soon. We look forward to making it easier for scientists everywhere to use GenAI for drug discovery and development. https://lnkd.in/gVrA_zhu
Like Comment
To view or add a comment, sign in
Saju John P

Head AI Strategy & Innovation | Strategy Consulting, Advising Clients | Building AI into the Core by Integrating AI, CX & Governance
2mo
Report this post
#GenAI is making its impact in unprecedented ways - that includes ' generating' protein structures that does not exist today! The impact is huge given Proteins form the building blocks of life through providing structural components like cells and tissues, Harmons that regulate metabolism and behavior, and the Immune cells that prevents diseases. Lets get over the Gartner Hype cycles to realize tangible and real achievements and value created by #AI Matt Garman, Generative AI Allie K. Miller Gartner
Matt Garman Matt Garman is an Influencer
2mo Edited

What’s happening with generative AI in healthcare & life sciences is pretty exciting. Today, EvolutionaryScale launched their cutting-edge ESM3 model for researchers and scientists, and it’s available on Amazon Web Services (AWS). ESM3 has the remarkable ability to generate entirely new proteins that have never existed before, allowing for “programmable biology.” Models like ESM3 have the potential to significantly speed drug discovery timelines and lower costs. The open-source ESM3 is available today through Amazon SageMaker and AWS HealthOmics, with the full model family coming to these services and Amazon Bedrock soon. We look forward to making it easier for scientists everywhere to use GenAI for drug discovery and development. https://lnkd.in/gVrA_zhu
Like Comment
To view or add a comment, sign in
Christopher Niederman

Managing Director, AWS Industries and Partner Solutions at Amazon
2mo
Report this post
Exciting breakthroughs in generative AI for healthcare and life sciences! 🔬 The new ESM3 model, now available on @amazon-web-services, will help researchers speed drug discovery and development, potentially leading to new and novel disease treatments. It’s one of the many ways AWS is having a positive impact through responsible #GenAI. I'm excited to see what the future holds! What are your thoughts on the potential of GenAI in healthcare, life sciences, and beyond? #GenerativeAI #DrugDiscovery #LifeSciences #Healthcare #Innovation
Matt Garman Matt Garman is an Influencer
2mo Edited

What’s happening with generative AI in healthcare & life sciences is pretty exciting. Today, EvolutionaryScale launched their cutting-edge ESM3 model for researchers and scientists, and it’s available on Amazon Web Services (AWS). ESM3 has the remarkable ability to generate entirely new proteins that have never existed before, allowing for “programmable biology.” Models like ESM3 have the potential to significantly speed drug discovery timelines and lower costs. The open-source ESM3 is available today through Amazon SageMaker and AWS HealthOmics, with the full model family coming to these services and Amazon Bedrock soon. We look forward to making it easier for scientists everywhere to use GenAI for drug discovery and development. https://lnkd.in/gVrA_zhu
2 Comments
Like Comment
To view or add a comment, sign in
Arinze Okigbo

Trinity College’28 | Thacher’24 | Tyree Innovation Fellow | Harvard SSP’22 | Tech enthusiast
2mo
Report this post
Artificial intelligence (AI) holds immense promise for transforming numerous fields, from healthcare and finance to education and transportation. The potential for AI to contribute to the medical field is particularly compelling. Given its ability to process vast amounts of data and identify complex patterns, AI could play a significant role in accelerating the discovery of treatments for diseases that have previously defied conventional medical approaches, such as cancer and AIDS. By leveraging AI's capabilities, researchers may be able to uncover potential solutions that could lead to groundbreaking advancements in the treatment of these challenging and persistent health issues.ArtificialIntelligence #MedicalResearch #HealthcareInnovation #DataProcessing #DiseaseTreatment #ResearchAdvancements
Matt Garman Matt Garman is an Influencer
2mo Edited

What’s happening with generative AI in healthcare & life sciences is pretty exciting. Today, EvolutionaryScale launched their cutting-edge ESM3 model for researchers and scientists, and it’s available on Amazon Web Services (AWS). ESM3 has the remarkable ability to generate entirely new proteins that have never existed before, allowing for “programmable biology.” Models like ESM3 have the potential to significantly speed drug discovery timelines and lower costs. The open-source ESM3 is available today through Amazon SageMaker and AWS HealthOmics, with the full model family coming to these services and Amazon Bedrock soon. We look forward to making it easier for scientists everywhere to use GenAI for drug discovery and development. https://lnkd.in/gVrA_zhu
Like Comment
To view or add a comment, sign in
Rafael Neitzel ⛳️🏌️

Managing Director & Natural Resources Lead at Accenture
2mo
Report this post
Today I've shared a post about the doors GenAI can open in Energy Transition and in Health & Life Sciences is no different. To correlate and analyze huge amounts of non structured data and knowledge equals to almost super human capabilities at the touch of your fingers. It's like having decades of experience and insights to serve you with unprecedented speed. It can be applied as well over Industrial performance & maintenance spaces.
Matt Garman Matt Garman is an Influencer
2mo Edited

What’s happening with generative AI in healthcare & life sciences is pretty exciting. Today, EvolutionaryScale launched their cutting-edge ESM3 model for researchers and scientists, and it’s available on Amazon Web Services (AWS). ESM3 has the remarkable ability to generate entirely new proteins that have never existed before, allowing for “programmable biology.” Models like ESM3 have the potential to significantly speed drug discovery timelines and lower costs. The open-source ESM3 is available today through Amazon SageMaker and AWS HealthOmics, with the full model family coming to these services and Amazon Bedrock soon. We look forward to making it easier for scientists everywhere to use GenAI for drug discovery and development. https://lnkd.in/gVrA_zhu
Like Comment
To view or add a comment, sign in

2,242 followers

84 Posts

View Profile Follow

Gurvinder Kaur Mahajan’s Post

More Relevant Posts

Explore topics